- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05084443
Effect of Roselle-based Drink on Blood Pressure and Skin
October 19, 2021 updated by: Chin Kun Wang, Chung Shan Medical University
Effect of Roselle-based Drink on Blood Pressure, Antioxidative Activity and Skin Condition
This randomized, placebo-controlled, double-blind, and cross-over study was designed to check whether the roselle-based drink (2 bottles every day) can alter blood pressure and skin condition in elderly healthy subjects.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The subjects were assigned into two groups (control group and test group), each group subject was requested to drink 2 bottles every day (100 mL/bottle, one in the morning and another in the evening), the rate of drinking is 75.42%.
There are 39 subjects (25 females and 14 males) completely involved in the thirteen-month trial (cross-over).
Blood samples were collected at the initial, 3rd, 6th, 7th, 10th, 13th months of the trial.
Skin examinations were performed at the initial, 6th, 7th, 13th months.
Study Type
Interventional
Enrollment (Actual)
52
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Taichung
-
Taichung city, Taichung, Taiwan, 40201
- Chung Shan Medical University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 81 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy adults
- Subjects should not be under any medication
- Subject must be able to drink
Exclusion Criteria:
- Subjects with chronic renal, liver or cardiac disorders, Diabetes, hyperlipidemia.
- Also pregnant women, chain smokers, high alcohol consumers should not be included.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Placebo/Control
Placebo drink-- Orally (200 ml/day)
|
Roselle and placebo drink for 6 months
Other Names:
|
Experimental: Roselle Based drink (Test)
Roselle-Based Drink--- Orally (200 ml/day)
|
Roselle and placebo drink for 6 months
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood pressure by sphygmomanometer (mmHg)
Time Frame: 6 months
|
Both systolic and diastolic blood pressure were changed after Roselle drink
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Chin-Kun Wang, Ph.D, Chung Shan Medical University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 11, 2017
Primary Completion (Actual)
June 15, 2018
Study Completion (Actual)
October 19, 2018
Study Registration Dates
First Submitted
September 29, 2021
First Submitted That Met QC Criteria
October 18, 2021
First Posted (Actual)
October 19, 2021
Study Record Updates
Last Update Posted (Actual)
October 26, 2021
Last Update Submitted That Met QC Criteria
October 19, 2021
Last Verified
October 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- CS11102
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Other Skin and Subcutaneous Infections
-
Gia Dinh People HospitalCompletedSkin and Subcutaneous Tissue InfectionVietnam
-
Trius Therapeutics LLCCompletedSkin and Subcutaneous Tissue Bacterial InfectionsUnited States, Argentina, Australia, Brazil, Germany, Mexico, New Zealand, Poland, Russian Federation, South Africa, Spain
-
Federico II UniversityWithdrawnInfection of Skin and/or Subcutaneous TissueItaly
-
Islamic Azad University of MashhadCompletedSkin and Subcutaneous Tissue Fungal InfectionsIran, Islamic Republic of
-
Melinta Therapeutics, Inc.CompletedSkin and Subcutaneous Tissue Bacterial InfectionsUnited States
-
Melinta Therapeutics, Inc.CompletedSkin and Subcutaneous Tissue Bacterial InfectionsUnited States, Croatia, Israel, Latvia, Russian Federation, Spain, Ukraine
-
Ahmed A. H. AbdellatifUnknownSkin and Subcutaneous Tissue DisordersEgypt, Saudi Arabia
-
Melinta Therapeutics, Inc.CompletedSkin and Subcutaneous Tissue Bacterial Infections | Skin Structures and Soft Tissue InfectionsUnited States, Argentina, Brazil, Bulgaria, Chile, Estonia, Georgia, Hungary, Korea, Republic of, Latvia, Mexico, Moldova, Republic of, Peru, Romania, Slovakia, Taiwan
-
Gary PeksaStony Brook University; Kaiser Permanente; The University of Texas Health Science... and other collaboratorsWithdrawnAbscess of Skin and/or Subcutaneous Tissue
-
Trius Therapeutics LLCCompletedSkin and Subcutaneous Tissue Bacterial InfectionsUnited States, Argentina, Brazil, Canada, Czechia, Germany, Hungary, Latvia, Peru, Slovakia, Ukraine
Clinical Trials on Drink
-
Virginia Polytechnic Institute and State UniversityCompletedCardiovascular Risk FactorUnited States
-
University of the PacificCompletedCardiovascular DiseasesUnited States
-
Maastricht University Medical CenterTop Institute Food and NutritionCompletedMuscle Loss in ElderlyNetherlands
-
Mayo ClinicCompletedCardiovascular System | Hemodynamics | Energy DrinksUnited States
-
Mondelēz International, Inc.Reading Scientific Services Ltd.CompletedGlycaemic Index | Glycaemic ResponseUnited Kingdom
-
University of LausanneCompleted
-
Wageningen UniversityMaastricht University Medical Center; Top Institute Food and NutritionCompleted
-
University of LimerickCompleted